Clinical Trial Update: An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for MK-0869-071 evaluating prevention of chemotherapy-induced nausea and vomiting; the study in breast cancer patients has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• MK-0869-071

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Nausea, Vomiting | Phase 4 | Status: COMPLETED